{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:47:40Z","timestamp":1790315260893,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1998,8,1]],"date-time":"1998-08-01T00:00:00Z","timestamp":901929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[1998,8]]},"DOI":"10.1006\/exnr.1998.6845","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T23:00:46Z","timestamp":1033945246000},"page":"214-220","source":"Crossref","is-referenced-by-count":32,"title":["MPTP-Induced Hemiparkinsonism in Nonhuman Primates 6\u20138 Years after a Single Unilateral Intracarotid Dose"],"prefix":"10.1006","volume":"152","author":[{"given":"Marina E.","family":"Emborg-Knott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward F.","family":"Domino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/exnr.1998.6845_EN986845RF1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF02260914","article-title":"Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease","volume":"5","author":"Baas","year":"1993","journal-title":"J. Neural. Trans. Parkinson's Dis. Dement. Sect."},{"key":"10.1006\/exnr.1998.6845_EN986845RF2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0024-3205(86)90431-5","article-title":"Hemiparkinsonism in monkeys after unilateral carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"39","author":"Bankiewicz","year":"1986","journal-title":"Life Sci."},{"key":"10.1006\/exnr.1998.6845_EN986845RF3","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.1998.6845_EN986845RF4","first-page":"76","article-title":"Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism","volume":"9","author":"Calne","year":"1994","journal-title":"Mov. Disord."},{"key":"10.1006\/exnr.1998.6845_EN986845RF5","series-title":"The Road to Self-Sustaining Populations","article-title":"Southeast asian primates","author":"Chivers","year":"1985"},{"key":"10.1006\/exnr.1998.6845_EN986845RF6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/syn.890140205","article-title":"In vivo11","volume":"14","author":"DaSilva","year":"1993","journal-title":"Synapse"},{"key":"10.1006\/exnr.1998.6845_EN986845RF7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","article-title":"Chronic parkinsonism secondary to intravenous injection of meperidine analogues","volume":"1","author":"Davis","year":"1979","journal-title":"Psychiatr. Res."},{"key":"10.1006\/exnr.1998.6845_EN986845RF8","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1471-4159.1996.66020658.x","article-title":"Estrogen alters MPTP-induced neurotoxicity in female mice: Effects on striatal dopamine concentration and release","volume":"66","author":"Deuzen","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.1998.6845_EN986845RF9","first-page":"2126","article-title":"Rotational asymmetry in nonhuman primates 6\u20138 years after a single unilateral intracarotid (ica) MPTP infusion","volume":"22","author":"Domino","year":"1996","journal-title":"Soc. Neurosci. Abst."},{"key":"10.1006\/exnr.1998.6845_EN986845RF10","first-page":"1387","article-title":"Relative potency and efficacy of some dopamine agonists with varying selectivities for D1 and D2 receptors in MPTP-induced hemiparkinsonian monkeys","volume":"265","author":"Domino","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/exnr.1998.6845_EN986845RF11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0925-4927(92)90023-W","article-title":"Positron emission tomography with18","volume":"45","author":"Doudet","year":"1992","journal-title":"Psychiatr. Res. Neuroimag."},{"key":"10.1006\/exnr.1998.6845_EN986845RF12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0306-4522(86)90102-8","article-title":"Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys","volume":"18","author":"Eidelberg","year":"1986","journal-title":"Neurosci."},{"key":"10.1006\/exnr.1998.6845_EN986845RF13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0306-4522(89)90212-1","article-title":"Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: Biochemical changes in striatal regions","volume":"33","author":"Elsworth","year":"1989","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1998.6845_EN986845RF14","first-page":"2126","article-title":"MPTP induced asymmetric parkinsonism in nonhuman primates 6\u20138 years after a unilateral (ica) dose","volume":"22","author":"Emborg","year":"1996","journal-title":"Soc. Neurosci. Abstr."},{"key":"10.1006\/exnr.1998.6845_EN986845RF15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0006-8993(88)91111-0","article-title":"An electron microscopic study of MPTP-induced inclusion bodies in an old monkey","volume":"448","author":"Forno","year":"1988","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1998.6845_EN986845RF16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0006-8993(96)01366-2","article-title":"6-[18F]Fluoro-lm","volume":"750","author":"Jordan","year":"1997","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1998.6845_EN986845RF17","series-title":"Psychopharmacology, The Fourth Generation of Progress","first-page":"1479","article-title":"Parkinson's disease","author":"Korczyn","year":"1995"},{"key":"10.1006\/exnr.1998.6845_EN986845RF18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mds.870060205","article-title":"Oral levodopa dose-response study in MPTP induced hemiparkinsonian monkeys: Assessment with a new rating scale for monkey parkinsonism","volume":"6","author":"Kurlan","year":"1991","journal-title":"Mov. Disord."},{"key":"10.1006\/exnr.1998.6845_EN986845RF19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410290618","article-title":"The time course and magnitude of spontaneous recovery produced by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys","volume":"29","author":"Kurlan","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.6845_EN986845RF20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1006\/exnr.1998.6845_EN986845RF21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0006-8993(84)90777-7","article-title":"Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the squirrel monkey","volume":"292","author":"Langston","year":"1984","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1998.6845_EN986845RF22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/mds.870090112","article-title":"Unified Parkinson's Disease Rating Scale characteristics and structure. The cooperative multicentric group","volume":"9","author":"Martinez-Martin","year":"1994","journal-title":"Mov. Disord."},{"key":"10.1006\/exnr.1998.6845_EN986845RF23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ana.410340306","article-title":"Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices","volume":"34","author":"Pate","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.6845_EN986845RF24","doi-asserted-by":"crossref","first-page":"295s","DOI":"10.1016\/0197-0186(92)90255-P","article-title":"Striatal and non-striatal neurotransmitter changes in MPTP-parkinsonism in rhesus monkeys: The symptomatic vs the asymptomatic condition","volume":"20","author":"Pifl","year":"1992","journal-title":"Neurochem. Int."},{"key":"10.1006\/exnr.1998.6845_EN986845RF25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0028-3908(87)90051-7","article-title":"Older dopaminergic neurons do not recover from the effects of MPTP","volume":"26","author":"Ricaurte","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1006\/exnr.1998.6845_EN986845RF26","first-page":"45","article-title":"Interrater reliability of the United Parkinson's Disease Rating Scale motor examination","volume":"5","author":"Richards","year":"1993","journal-title":"Transm. Parkinson's Dis. Dement. Sect."},{"key":"10.1006\/exnr.1998.6845_EN986845RF27","series-title":"Psychopharmacology, The Fourth Generation of Progress","first-page":"227","article-title":"Biochemical pharmacology of midbrain dopaminergic neurons","author":"Roth","year":"1995"},{"key":"10.1006\/exnr.1998.6845_EN986845RF28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0006-8993(94)01332-C","article-title":"Differential recovery of volitional motor function, lateralized cognitive function, dopamine agonist-induced rotation and dopaminergic parameters in monkeys made hemi-parkinsonian by intracarotid MPTP infusion","volume":"672","author":"Schneider","year":"1995","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1998.6845_EN986845RF29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0166-2236(89)90135-5","article-title":"The role of environmental toxins in the etiology of Parkinson's disease","volume":"12","author":"Tanner","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1006\/exnr.1998.6845_EN986845RF30","series-title":"Handbook of Tremor Disorders","article-title":"MPTP-induced parkinsonism and tremor","author":"Tetrud","year":"1995"},{"key":"10.1006\/exnr.1998.6845_EN986845RF31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0684.1988.tb00364.x","volume":"17","year":"1988","journal-title":"J. Med. Primatol."},{"key":"10.1006\/exnr.1998.6845_EN986845RF32","series-title":"The Guide for the Care and Use of Laboratory Animals","year":"1985"},{"key":"10.1006\/exnr.1998.6845_EN986845RF33","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0028-3908(89)90122-6","article-title":"Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioral recovery from motor deficits induced by an earlier exposure to the neurotoxin","volume":"28","author":"Ueki","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1006\/exnr.1998.6845_EN986845RF34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","article-title":"Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol. Scand."},{"key":"10.1006\/exnr.1998.6845_EN986845RF35","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.410360513","article-title":"Positron emission tomography evidence for progression of human MPTP-induced dopaminergic lesions","volume":"36","author":"Vingerhoets","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1998.6845_EN986845RF36","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0306-4522(87)90178-3","article-title":"An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset","volume":"23","author":"Waters","year":"1987","journal-title":"Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488698968455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488698968455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T05:11:54Z","timestamp":1703913114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488698968455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["S0014488698968455"],"URL":"https:\/\/doi.org\/10.1006\/exnr.1998.6845","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}